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Abstract: Studies assessing maternal dietary intakes and the relationship with birthweight 
are inconsistent, thus attempting to draw inferences on the role of maternal nutrition in 
determining the fetal growth trajectory is difficult. The aim of this review is to provide 
updated evidence from epidemiological and randomized controlled trials on the impact of 
dietary and supplemental intakes of omega-3 long-chain polyunsaturated fatty acids, zinc, 
folate, iron, calcium, and vitamin D, as well as dietary patterns, on infant birthweight. A 
comprehensive review of the literature was undertaken via the electronic databases Pubmed, 
Cochrane Library, and Medline. Included articles were those published in English, in 
scholarly journals, and which provided information about diet and nutrition during 
pregnancy and infant birthweight. There is insufficient evidence for omega-3 fatty acid 
supplements’ ability to reduce risk of low birthweight (LBW), and more robust evidence 
from studies supplementing with zinc, calcium, and/or vitamin D needs to be established. 
Iron supplementation appears to increase birthweight, particularly when there are increases in 
maternal hemoglobin concentrations in the third trimester. There is limited evidence 
supporting the use of folic acid supplements to reduce the risk for LBW; however, 
supplementation may increase birthweight by ~130 g. Consumption of whole foods such as 
fruit, vegetables, low-fat dairy, and lean meats throughout pregnancy appears beneficial for 
appropriate birthweight. Intervention studies with an understanding of optimal dietary patterns 
may provide promising results for both maternal and perinatal health. Outcomes from these 
studies will help determine what sort of dietary advice could be promoted to women during 
pregnancy in order to promote the best health for themselves and their baby. 
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Optimal nutrition supply to the developing fetus is paramount in achieving appropriate fetal growth 
and development. During pregnancy, dietary energy and nutrient requirements are generally increased 
to support increased maternal metabolism, blood volume and red cell mass expansion, and the delivery 
of nutrients to the fetus [1,2]. In a recent systematic review and meta-analysis of 90 dietary studies 
among pregnant women in developed countries (n = 126,242), compared to dietary recommendations in 
the specific countries, energy and fiber intakes were generally lower, total fat and saturated fat intakes 
were higher, and carbohydrate intake was borderline or lower than recommendations [3]. Key nutrients 
including folate, iron, zinc, calcium, vitamin D, and essential fatty acids function to promote red blood 
cell production, enzyme activity, bone development, and brain development. Current evidence indicates, 
however, that micronutrient intake during pregnancy is less than optimal [4]. This is of concern given 
the current consensus that maternal nutrition is relevant to both the short- and long-term health of the infant. 
Human studies assessing maternal dietary intakes on birth outcomes date back to the early 1940s, 
when the appropriate energy and protein intakes to achieve a full-term infant (≥2500 g) were  
uncertain [5–8]. However, the available evidence at the time suggested that mothers with insufficient 
weight gain during pregnancy had higher rates of premature birth than mothers with appropriate 
pregnancy weight gain [9,10]. Undernutrition, then, was seen to markedly affect pregnancy outcome, 
potentially through inadequate energy availability to the developing fetus. Comparatively, the recent 
surge in the prevalence of overweight and obesity worldwide has been identified as another significant 
complication of pregnancy [11–13], potentially via fetal exposure to excess energy availability. The 
long-term detrimental influence of maternal obesity and excess maternal nutrition on the risk of disease 
in childhood and beyond has been described [14–16]. 
Unfortunately, there has been no single comprehensive review examining infant birthweight related 
to important maternal nutrients that may play a role in fetal birthweight. Therefore, this review will 
provide updated information from epidemiological studies and the latest evidence from systematic 
reviews/meta-analyses on the impact of long chain omega 3 polyunsaturated fatty acids (LC n3 PUFA), 
zinc, iron, folate, calcium, and vitamin D on fetal birthweight. These nutrients were chosen due to their 
nutritional importance in pregnancy and the potential mechanisms relevant to birthweight. A distinction 
will be made between studies conducted in developed and developing countries due to differences in 
dietary intakes and prevalence of infants with low birthweight (LBW). Maternal nutrient deficiencies 
can occur in women who are of normal weight, obese, or underweight, and thus the impact of nutrient 
deficiencies will be discussed in the context of pregnancy undernutrition and overnutrition. The impact 
of whole dietary patterns on birthweight will also be discussed in order to highlight diet quality as a 
global holistic marker of nutritional intake. 
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2. Methods 
A comprehensive review of the literature was undertaken via the electronic databases PubMed, 
Cochrane Library, and Medline. The most recent systematic reviews and meta-analyses were used to 
capture information from epidemiological and RCTs, with any subsequent studies published after the 
systematic reviews also included. Reviews were initially searched for using the search keywords “omega 
3 fatty acids birthweight small for gestational age pregnancy”; “zinc birthweight small for gestational 
age pregnancy”; “iron birthweight small for gestational age pregnancy”; “folate birthweight small for 
gestational age pregnancy”; “calcium birthweight small for gestational age pregnancy”; “vitamin D 
birthweight small for gestational age pregnancy”; and “diet birthweight small for gestational age 
pregnancy”. Articles were limited to human studies published in English, and articles were included 
where they provided information about diet and nutrition during pregnancy and the birthweight 
outcomes of the fetus. Outcomes focussed on low birth weight (LBW: <2500 g) and small for gestational 
age (SGA: <10th percentile for gestational age), but also included intrauterine growth restriction (IUGR: 
<3rd percentile for gestational age) and large for gestational age (LGA: >90th percentile for gestational 
age); and macrosomia (>4000 g at birth). Key mechanistic studies were included to highlight the 
importance of different nutrients during pregnancy and transfer through the placenta. Supporting  
animal studies were included where there was a lack of human studies on the effects of maternal under- 
and overnutrition. 
3. Review 
3.1. Undernutrition and Fetal Growth 
The major determinant of intrauterine fetal growth is the placental supply of nutrients to the fetus, 
which is dependent upon placental size, morphology, and blood supply [17]. Several animal studies have 
shown direct relationships between placental size and birthweight [18,19]. Experimental restriction of 
placental growth [20–22], food restriction [23], and isocaloric low protein diets [24,25] resulted in 
reduced placental weight and altered placental efficiency, leading to reduced birthweight and IUGR. The 
timing of delivery of nutrients through the placenta is also important [26]. In pregnant sheep, severe 
undernutrition during the peri-conceptual period led to preterm delivery [17]; global undernutrition in 
early pregnancy reduced the placental:fetal weight ratio [27]; global undernutrition in early to  
mid-gestation increased placental size [28,29]; and global undernutrition in late gestation reduced fetal 
growth [30]. In rats, a low protein diet in early pregnancy increased placental growth [31], whereas in late 
pregnancy there was reduced fetal weight [32]. A recent review has neatly summarized the animal 
models, demonstrating how dietary manipulation impacts perinatal programming [33]. It can be summarized 
that following maternal reduced nutrition (i.e., a low protein isocaloric diet, or global food restriction at 
20%–70% calorie intake), offspring exhibited structural disorganization and impaired programming of 
the appetite-regulating system located in the hypothalamus. Due to changes in orexigenic pathways and 
increased white adipose tissue, the potential increased risk of obesity later in life is inevitable. 
Maternal undernutrition during critical periods in humans may also influence fetal adipocyte 
metabolism and fat mass, leading to obesity in later life [34]. Thus, alterations in fetal nutritional supply 
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can drive developmental adaptations influencing growth and metabolism. These alterations affect not 
only postnatal outcomes but also contribute to increased susceptibility to disease in later life. 
In a systematic review and meta-analysis of 78 studies (n = 1,025,794 women), risk of preterm birth was 
increased in the cohort studies of underweight women by 29%, and a 64% increased risk for LBW [35]. Low 
birthweight is a proxy for maternal undernutrition [36]. It is associated with reduced fat mass and lean 
mass [37,38], poor cognition in childhood [39], and increased risk for type 2 diabetes [40] and high 
blood pressure [41,42] in adulthood. These studies support a link between maternal nutrition, infant 
birthweight, and the short- and long-term consequences. However, there are limited epidemiological 
studies suggesting the optimal maternal dietary intakes for optimal infant birthweight. 
3.2. Epidemiological Studies and Randomized Controlled Trials Assessing Birthweight 
3.2.1. Long chain omega-3 Polyunsaturated Fatty Acids 
Fatty acids are among the essential nutrients for intrauterine growth [43]. Among the long chain 
omega-3 polyunsaturated fatty acids (LC n3 PUFA), docosahexanoic acid (DHA) plays a critical role in 
fetal growth and central nervous system development. It has been estimated that the average complete 
DHA accretion rate in utero is 43 mg/kg/day [44]. As the fetus does not accumulate appreciable amounts 
of fat until the last trimester of gestation, if adequate DHA is not available during this critical window 
of development, the deleterious effect on the brain dopaminergic and serotonergic systems is  
irreversible [45]. There has been much recent investigation into the importance of LC n3 PUFA in 
pregnancy [46–48] and associations between LC n3 PUFA intakes and birth outcomes is emerging. 
The most recent review that included 14 epidemiological studies assessing fish/seafood intake on 
birth outcomes revealed a positive association in 6 of the studies; 4 studies showed an inverse association, 
and the remaining studies revealed no association [49]. Overall in these studies, daily intake of fish 
ranged from 3.4 g to 47 g, or 8–12 fish meals per month. It is noted that 11 of the studies collected dietary 
data during pregnancy, while 3 studies collected dietary information following delivery [49]. 
There is emerging research, particularly in developed countries on n3 fatty acid supplementation and 
birthweight. The most recent meta-analysis of 15 RCTs reported that birthweight was slightly higher 
among infants born to women in the LC n-3 PUFA supplemented group compared to placebo (RR 42.2; 
95% CI: 14.8, 69.7); however, risk of LBW was not significantly different (RR 0.92; 95% CI: 0.83,  
1.02) [49] (Table 1). In a further phase 3 double blind RCT with smaller sample size (n = 303), 
supplementation with 600 mg/day DHA from <20 week gestation to birth led to a 172 g greater 
birthweight [50]. Interestingly, it was reported that only 78% of the capsules were consumed, thus mean 
daily intakes of DHA was lower than anticipated (469 mg/day). The conflicting evidence of an increase 
in birthweight with LC n3 PUFA supplementation and the lack of studies in developing countries suggest 
the need for further, high-quality studies to be replicated and confirmed. Moreover, the clinical 
significance of an increase in birthweight of 42 g and 172 g, identified by Imhoff-Kunsch et al. [49] and 
Carlson et al. [50], is unclear, particularly as supplementation only marginally affected LBW. 
 
Nutrients 2015, 7 157 
 
3.2.2. Zinc 
Zinc is essential for normal fetal growth and development [51]. In the USA, dietary zinc intake is 
recommended to increase from 8 mg/day in non-pregnant women to 11 mg/day during gestation [52]. 
Most of the zinc gained is deposited in the fetus and in the uterine muscle. Several studies have identified 
that maternal zinc absorption is not significantly different throughout gestation or compared to the  
non-pregnant state [51,53,54], but does appear to increase during lactation [51,55]. Potential mechanisms 
for adjustment of zinc metabolism may include reduced endogenous gastrointestinal zinc excretion [51,56] 
or the release of maternal tissue zinc [57]. 
Zinc deficiency is thought to influence embryonic and fetal development through reduced cell 
proliferation, reduced protein synthesis, or reductions in rates of tubulin polymerization, rather than 
increased rates of cellular oxidative damage, increased rates of apoptosis, or reduced binding of 
hormones and transcription factors dependent on zinc-finger regions [58,59]. Studies in animals have 
identified that zinc deficiency is teratogenic, such that it can interfere with normal embryonic 
development. For instance, offspring of mother hens with zinc deficiency were born with several skeletal 
defects and abnormalities of the brain, with many deaths occurring within 4 days [60], and when rats 
were fed a zinc-deficient diet during pregnancy, fewer offspring were born and many were growth-
retarded, with multiple anomalies [61]. The consideration that zinc deficiency is a teratogenic risk in 
humans may be supported by the correlation of low plasma zinc concentrations in the first and third 
trimesters of pregnancy with respective increases in risk for malformations [62] and LBW [63].  
Other adverse consequences of maternal zinc deficiency include increased maternal mortality, prolonged 
labor, prematurity [64], and adverse fetal development [65]. 
In a review of 46 studies conducted in developed and developing countries, 23 studies reported a 
positive relationship between maternal zinc concentrations and birthweight [64]. Since publication of 
that review, 3 studies have reported on zinc and birthweight, all in developing countries: 2 studies 
reported no relationship between low maternal zinc status and LBW infants [66,67], whereas among 
pregnant women from Tanzania, increased odds of LBW were observed with low maternal zinc 
concentrations [68]. Only a few studies assessing maternal dietary intakes of zinc were found, of which 
a study among women from New Jersey (n = 818) reported those with intakes of ≤6 mg/day had a  
two-fold increased risk of LBW compared to intakes >6.1 mg/day [69]; however, dietary intakes of zinc 
between 8 and 11 mg/day were not associated with LBW [70,71]. Currently there is insufficient evidence 
to presume that maternal zinc deficiency is teratogenic or that maternal zinc deficiency is related to 
neonatal birthweight. Further studies are required assessing mechanistic pathways between maternal zinc 
status and infant birthweight. 
In the most recent Cochrane review of 20 RCTs, compared to placebo (or other micronutrient 
supplementation combinations), zinc supplementation (5–44 mg/day) had no effect on reducing risk for 
LBW or SGA [72] (Table 1). Similarly, in a systematic review and meta-analysis of 20 trials that was 
published in the same year, maternal zinc supplementation (between 5 and 50 mg/day) had no effect on 
LBW or SGA [73] (Table 1). In that review, however, only 6 trials were deemed to be of high quality, 
and the overall quality of evidence for LBW or SGA was very low. More robust evidence from 
supplementation studies needs to be established, and appropriate biomarkers to assess zinc status may 
need to be developed to support increasing dietary zinc intakes during pregnancy for infant birthweight. 
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3.2.3. Iron 
Dietary iron requirements during pregnancy increase due to the expansion of red cell mass  
to accommodate fetal and placental growth, and to allow for the blood loss that occurs at delivery. 
Increased dietary iron requirements are difficult to achieve through diet alone, and beginning pregnancy 
with already low intakes increases the likelihood of outcomes such as preterm birth and LBW [74,75]. 
Thus, the prevalence of iron deficiency (with and without anemia) is reported to increase during each 
trimester [76,77]. 
Only 1 study was located assessing dietary iron intakes on fetal body weight. In this study among 
1274 pregnant women aged 18–45 years from the UK, it was found that for every 10 mg increase in 
dietary iron intake, fetal birthweight was predicted to increase by 70 g (95% CI: 10, 130; p = 0.02); 
however, when adjusting for maternal age, cotinine levels, alcohol intake, maternal weight, height, parity, 
ethnicity, gestational age, and fetal sex, the change of 34 g was not significant [78]. 
There is considerably more information on maternal iron status and birthweight. A recent review of 
25 observational studies revealed anemia (defined as Hb < 110 g/L) during pregnancy increased the risk 
for LBW (OR 1.25; 95% CI: 1.08, 1.25) compared to non-anemic women (Hb ≥ 110 g/L); however, 
when including only the nine studies with adjusted estimates, this was no longer significant (aOR 1.13; 
95% CI: 0.94, 1.35) [79]. Interestingly, there was a 30% increased risk for LBW when anemia occurred 
during the first two trimesters of pregnancy compared to the final trimester. Maternal anemia was not 
associated with birthweight or SGA, and there was no significant difference in birthweight between high- 
and low-income countries [79]. 
Some studies have also assessed ferritin concentration, which is an indicator of iron stores. Both low 
ferritin (<12 g/L, indicating depleted iron stores) and high ferritin (≥60 g/L) levels were significantly 
associated with lower birthweight (106 g and 123 g, respectively) compared with women with intermediate 
ferritin concentrations [74]. In a sample of 580 black women from Alabama, USA, plasma ferritin levels 
in the highest quartile at 19 weeks (95.8 µg/L), 26 weeks (55.4 µg/L), and 36 weeks (41.4 µg/L) were 
associated with a lower mean birthweight than those in the lower three quartiles, by 142–226 g [80], 
whereas infants of mothers with depleted iron stores (n = 51, serum ferritin <10.0 µg/L) had a lower 
birth weight by ~336 g compared to infants of mothers with adequate serum ferritin >20.0 µg/L (n = 20) [81]. 
A final study reported serum ferritin <12 µg/L was associated with 192 g lower birthweight [82]. 
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Table 1. Summary of supplementation studies and relative risk for low birthweight. 
Study Population Supplementation Intervention RR (95% CI) 
Long chain omega-3 polyunsaturated fatty acids 
Meta-analysis of 15 RCTs [49] 80 mg/day–2.2 g/day (8 trials, n = 3247) 0.92 (0.83, 1.02) 
Zinc 
Cochrane review of 20 RCTs (n > 15,000 women) [72] 
5–44 mg/day (14 trials, n = 5643) 0.93 (0.78, 1.12) 
5–44 mg/day (8 trials, n = 4252) 1.02 (0.94, 1.11) a 
Systematic review and meta-analysis of 20 RCTs (n = 6209) [73] 
15–50 mg/day (n = 11 trials, n = 937/5416 LBW babies) 1.06 (0.91, 1.23) 
25–45 mg/day (5 trials, n = 1155/3441 SGA babies) 1.03 (0.91, 1.23) a 
Iron 
Meta-analysis of 48 RCTs (n = 17,793) [79] 10–140 mg/day (n = 10 trials) 0.81 (0.71, 0.91) 
  0.84 (0.66, 1.07) a 
Folate 
Cochrane review of 31 trials (n = 17,771) [83] Dose range not reported (4 studies, n = 3113 on LBW) 0.83 (0.66, 1.04) 
Calcium 
Cochrane review of 21 trials (n = 16,602) [84] 
≥1000 mg/day (5 trials, n = 13,638, mainly calcium carbonate) 0.83 ( 0.63, 1.09) 
≥600 mg/day (5 trials, n = 1177, mainly calcium carbonate) 0.86 (0.61, 1.22) b 
Vitamin D 
Cochrane review of 6 trials on various maternal and infant 
outcomes (n = 623) [85] 
1000 IU/day; 600,000 IU at month 7 and 8; 1 dose of 200,000 IU in third 
trimester (3 trials, n = 463) 
0.48 (0.23, 1.01) b 
a small for gestational age; b intrauterine growth restriction. 
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In the same review described above [79], a meta-analysis on 16 RCTs was carried out that assessed 
iron supplementation compared to control supplementation on birthweight (Table 1). Iron-only 
supplementation led to a mean difference in birthweight of 40.8 g (0.97 to 80.6) and reduced LBW (RR 
0.81; 95% CI: 0.71, 0.91), but not SGA. Although duration of iron supplementation was not associated 
with birthweight, it was found that for every 10 mg increase in daily iron intake, birth weight increased by 
15.1 (6.0 to 24.2) g, and for every 10 g/L increase in mean Hb concentration in the third trimester or at 
delivery, birthweight increased by 143 (95% CI: 68, 218) g [79]. 
Mechanisms linking iron status to birthweight are not established. An early study identified an inverse 
relationship between hemoglobin levels and placenta weight [86], in which further possible roles of the 
placenta in the regulation of iron transfer and the transport proteins involved have been implicated [87–89]. 
Additional mechanistic studies are needed to better understand the link between iron status and 
birthweight, as multiple studies have reported positive effects. 
3.2.4. Folate 
Folate requirements are increased during pregnancy due to the demand of fetal growth [90]. It has 
long been established that folic acid at or around the time of conception reduces the risk for neural tube 
defects [91–93], and it is currently recommended that a 400 µg/day folic acid supplementation is taken 
three months before and early on in pregnancy [52,94,95]. However, the effect of routine folic acid 
supplementation on birth outcomes is not currently known. 
Maternal folate status is largely determined by folate supplement use and though a number of other 
factors such as dietary folate intake and genetic variations in genes [90]. Red blood cell folate (RBC) is 
a biomarker of long-term folate status reflecting the previous 2–4 months, while serum and plasma folate 
represent short-term folate status and are therefore commonly used to reflect current folate supplement 
use [96]. 
No systematic reviews were located that reported on folate status and birth outcomes. However, in 
the most recent review of the literature assessing folate status and birth outcomes [97], maternal RBC 
folate status appeared to be associated with birthweight (n = 5 studies), and there was an increased risk 
for SGA with low or decreasing RBC folate (125–300 nmol/L) in two of four studies. However the 
majority of these studies were of poor quality, folate status was collected at different time points during 
gestation, and some of the studies were underpowered and thus were unable to identify a meaningful 
outcome. Comparatively, a number of high-quality studies were identified that assessed serum or plasma 
folate on birth outcomes. Only 2 of 15 studies reported significant associations between high or 
increasing serum or plasma folate during pregnancy and increased birthweight, while 1 study showed a 
significantly decreased risk of LBW with increasing folate levels in the second trimester. Folic acid 
supplement use was identified in 18 studies, of which 5 reported positive outcomes with supplement use 
in the second and third trimesters; and there was mixed evidence reporting folic acid supplement use and 
LBW or SGA. Although the majority of these studies were of high quality, some studies reported pre-
conception folate intake and some RCTs were also summarized in the results. Thus, the ability to draw 
appropriate conclusions about the effect of dietary folate intake and folate status on birth outcomes is 
difficult. No further studies have been carried out since that review, further limiting the ability to 
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understand the impact of maternal folate intake on birth outcomes, and at what time point during 
gestation folate should be measured. 
In a Cochrane review assessing folic acid alone or with other micronutrients versus no folic acid 
(Table 1), the mean difference in birthweight was significantly greater in the folic acid supplement 
groups compared to no folic acid supplement (mean difference 135.75 g; 95% CI: 47.85, 223.68), but 
not LBW (RR 0.83; 95% CI: 0.66, 1.04; 4 studies, n = 3113 participants) [83]. In that review, it was 
revealed that supplementation typically took place from the 8th week of pregnancy until three days 
postpartum. The indication that most studies were also conducted 30–45 years ago suggests the need for 
current, well-designed clinical trials to assess the effectiveness of folic acid supplement use on birthweight 
parameters, given that current folic supplement use is recommended to assist other neonatal outcomes, 
namely neural tube defects. 
3.2.5. Calcium 
Calcium absorption and urinary calcium excretion are approximately two-fold higher during 
pregnancy compared to pre-conception or after delivery [98–100]. These changes are evidenced at the 
end of the first trimester and available for the peak fetal demands in the third trimester. Calcium is 
transported across the placenta by an active transport process, being important in many developmental 
functions and critical for skeletal development [101]. There does not appear to be an additional need for 
calcium in pregnancy [102]. 
Few studies have reported on associations between calcium intake and birthweight. Studies in 
developing countries have reported higher calcium intakes (≥1200 mg/day vs. <800 mg/day) were 
associated with higher birthweight (~3400 g vs. 3000 g) [71], particularly when calcium intakes reached 
dietary recommendations [103,104]. It is to be noted, however, that birthweight of 3000 g with lower 
daily calcium intake of 800 mg is not considered an inappropriate birthweight. 
In a recent Cochrane review of 21 trials, no effect of calcium supplementation was found for LBW 
or IUGR, despite all 5 trials providing high dose supplementation (≥1000 mg/day) [84] (Table 1). 
Comparatively, higher birthweights were apparent following calcium supplementation compared to 
placebo (mean difference 64.66 g; 95% CI: 15.75, 113.58) in 19 trials with 8287 women [84]; however, 
the clinical importance of an increase of 64 g is unknown. 
3.2.6. Vitamin D 
The major circulating form of vitamin D is 25-hydroxyvitamin D (25(OH)D) and the most biological 
potent form is calcitriol (1,25-dihydroxyvitamin D3) (1,25(OH)2D3)). 25(OH)D readily crosses 
experimentally perfused placentas in humans [105,106] and rodents [107], such that cord blood 
25(OH)D levels at term are typically three-quarters that of maternal values [108]. In comparison, 
1,25(OH)2D3 does not appear to cross the placenta, with lower levels detected in cord blood [109]. 
Although there is no recommended increase in vitamin D intake during pregnancy [95,110], it is apparent 
that neonates born to vitamin D-deficient mothers will also be deficient [111,112]. There is mixed 
evidence regarding the effect of maternal 25(OH)D on bone health at birth; however, studies assessing 
skeletal health in childhood suggest 25(OH)D levels during pregnancy may have more impact at this 
later stage [113]. 
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Currently, the estimated average requirement for calcium and vitamin D during pregnancy according 
to the Institute of Medicine (IOM) is 800 mg/day and 400 IU/day (10 µg/day), respectively [110]. The 
recommendation for calcium is similar to that reported by the National Health and Medical Research 
Council (NHMRC) in Australia (840 mg/day); however, the requirement for vitamin D is half (5 µg/day, 
200 IU/day) [95]. 
The most recent meta-analysis revealed that 25(OH)D insufficiency (<37.5 nmol/L) during pregnancy 
was associated with increased risk for small SGA (OR 1.85; 95% CI 1.52, 2.26, 6 studies) compared to 
higher 25(OH)D levels [114]. Importantly, even adjusting for confounders such as 25(OH)D 
concentration cut-offs (<37.5 and <80 nmol/L), gestational age (<16 and >16 weeks), and study design 
(case-control and other), the association remained significant. In the same review that included 4 studies 
on LBW, mothers with 25(OH)D concentrations <37.5 nmol/L during pregnancy had infants with lower 
birth weight (random weighted mean difference −130.92; 95% CI 186.69, 75.14 g) compared to infants 
of mothers with levels greater than this [114]. 
A Cochrane review of 3 RCTs identified vitamin D treatment alone as borderline significant in 
reducing risk for SGA compared to no supplements/placebo (Table 1) [85]. Currently, there is 
insufficient evidence to promote the use of a vitamin D supplement (with or without calcium) during 
pregnancy to reduce the risk of LBW babies. The NHMRC in Australia recommends consuming 5 µg/day 
vitamin D [95] whereas the IOM advocates 10 µg/day for those in the USA or Canada [110]. In Australia, 
it has also been suggested that pregnant women who receive regular exposure to sunlight do not require 
supplementation; however, for those who have little access to sunlight, a vitamin D supplement of  
10 µg/day would not be excessive [95]. Although various vitamin D supplements are currently on the 
market in doses ranging from 5 to10 µg, further studies are required to assess whether supplemental 
vitamin D can improve infant health outcomes. 
3.3. Dietary Pattern Studies 
Assessment of single nutrients on various study outcomes such as birthweight presents several caveats 
as a result of the highly interrelated nature of dietary exposures. Thus it is difficult to separate out the 
specific effects of nutrients or foods in relation to infant birthweight, disease risk, or other health 
outcomes. Studies assessing whole foods rather than specific nutrients may provide valuable information 
on optimal nutrition during pregnancy, and therefore dietary pattern analysis aims to overcome some of 
the difficulties that are often lost in nutrient-based analyses. Higher consumption of food groups within 
each identified dietary pattern indicates higher scores/adherence to this type of pattern. 
Among women participating in the Auckland Birthweight Collaborative study (n = 1714), higher 
scores on the traditional food pattern (characterized by fruit, vegetables, yogurt, and lean meat) in early 
pregnancy was associated with reduced odds for SGA (OR 0.86; 95% CI: 0.75, 0.99) [115]. Similarly, 
compared to the Western dietary pattern (n = 7619) characterized by a high intake of high-fat dairy, 
refined grains, processed meat, beer, and sweets, 26%–32% reduced odds for SGA were found for both 
the health conscious dietary pattern (n = 7479), characterized by a higher intake of fruits, vegetables, 
poultry, and breakfast cereals, and for the intermediate dietary pattern (n = 29,514), characterized by 
low fat dairy and fruit but also including some red meat, dairy, and vegetables [116]. Among women 
from Spain, higher scores on the Alternate-Healthy Eating Index in the first trimester were associated 
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with reduced risk of fetal growth restriction compared to women with the lowest score [117]. Among 
women participating in the Osaka Maternal and Child Health Study in Japan, those in the wheat products 
pattern (bread, confectionery, and soft drinks, n = 303) had infants with lower birthweight, and compared 
with women in the rice, fish, and vegetables pattern, women in the wheat products pattern had higher 
odds of an infant being born SGA (OR 5.2; 95% CI: 1.1, 24.4) [118]. 
In pregnant women from the Generation R study in the Netherlands, both low and medium adherence 
to the Mediterranean diet in the first trimester was associated with lower birthweight [119].  
In two population-based cohort studies from Spain, higher intakes of fish, legumes, and dairy products 
were associated with higher infant birthweight and reduced risk for IUGR, while intake of cereal, fruits, 
and nuts had no relationship with birthweight [120]. Similarly, in women from the Danish National Birth 
Cohort (n = 35,530), higher intake of Mediterranean foods reduced the odds for preterm birth [121]. 
The first dietary pattern analysis to assess pre-conception diet on perinatal outcomes was carried out 
in a sample of 309 pregnant women from an area of low socioeconomic status in Australia [122].  
The study revealed no association between any of the dietary patterns identified with LBW or SGA; 
however, there was an approximate 50% reduced risk for preterm delivery following the high protein 
and fruit pattern, and there was a 50% increased risk for preterm delivery following a high fat, sugar, 
and takeaway pattern [122]. 
There is emerging data on dietary pattern assessment and fetal growth. Generally, these studies were 
reported in large prospective cohorts, thus capturing a large sample size, which improves the generalizability 
to other populations. The single study that assessed pre-conception diet and perinatal outcomes warrants 
further investigation, as improving diet pre-conception presents an ideal opportunity to modify dietary 
intake prior to pregnancy in order to optimize birth outcomes. Nevertheless, these studies suggest that 
consumption of whole foods such as fruit, vegetables, low-fat dairy, and lean meats throughout 
pregnancy appears beneficial in reducing risk for LBW babies, but it is unclear if healthier food choices 
in a certain trimester are optimal. Assessing quantities of the different foods relevant to national food 
consumption guidelines would also be a valuable component to dietary pattern analyses. 
3.4. Summary 
According to the reviewed epidemiological studies, there does not appear to be any consistent or 
conclusive evidence regarding the optimal intake for maternal dietary LCPUFA, zinc, calcium, or 
vitamin D for optimal birthweight. Larger studies are needed that assess LCPUFA intakes and blood 
concentrations over the course of pregnancy, and to determine at what time point and at what level is 
most important in determining optimal birth outcomes. There is insufficient evidence to presume that 
maternal zinc deficiency is teratogenic or that maternal zinc deficiency is related to neonatal birthweight; 
therefore, further studies are required assessing mechanistic pathways between maternal zinc status and 
infant birthweight. Iron supplementation increases infant birthweight and the magnitude that was 
identified with higher Hb concentrations (i.e., for each 10 g/L increase in mean Hb concentration in late 
pregnancy or at delivery, birthweight increased by 143 g), could be critical for the survival of neonates 
born with lower birthweight. There is limited evidence supporting the use of folic acid supplements to 
reduce the risk for LBW; however, supplementation may increase birthweight by ~130 g. Further trials 
assessing calcium supplementation need to be undertaken, particularly among women with low baseline 
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calcium intakes, to support the few epidemiology studies identifying higher calcium intakes with higher 
birthweight. Serum 25(OH)D levels of at least 37.5 nmol/L appear optimal in reducing the risk for SGA 
and increasing birthweight; however, clarification as to what defines a normal 25(OH)D level is required, 
in addition to high-quality study designs. Currently there is not enough evidence to support the use of 
fish oil supplements to reduce the risk of LBW in low-risk or high-risk pregnancies, and more robust 
evidence from studies supplementing with zinc, calcium, and/or vitamin D needs to be established. 
Attempting to draw inferences on the role of maternal nutrition in determining the fetal growth trajectory 
is difficult. Dietary pattern studies appear to show positive associations between healthier dietary 
patterns and infant birthweight. In particular, foods such as lean meat, vegetables, fruit, whole grains, 
and low-fat dairy all contain beneficial nutrients such as protein, fiber, iron, zinc, calcium, and folate. 
Intervention studies assessing whole foods rather than specific nutrients may provide valuable information 
on optimal nutrition during pregnancy, and how certain dietary patterns improve maternal and perinatal 
outcomes. Outcomes from these studies will help determine what sort of dietary advice could be 
promoted to women during pregnancy in order to promote the best health for themselves and their babies. 
3.5. Overnutrition and Fetal Growth 
The global increase in overweight and obesity [11–13] indicates that more women entering pregnancy 
are overweight/obese [11,123]. Maternal BMI is a proxy measure of nutritional status [12,124–129]. 
Epidemiological studies have reported that maternal overweight (i.e., BMI ≥ 25 kg/m2) increases the  
risk for LGA and fetal macrosomia (Table 2). In a sample of women from Canada, class 3 obesity  
(BMI ≥ 40 kg/m2, n = 249) was protective against LBW (aOR 0.07; 95% CI: 0.01, 0.36), but not SGA, 
compared to women with normal BMI (18.5–24.9 kg/m2, n = 446); but class 3 obesity was also associated 
with LGA (aOR 4.29; 95% CI: 2.67, 6.89); birthweight > 4000 g (aOR 3.70; 95% CI: 2.22, 6.16) and 
birthweight > 4500 g (aOR 5.78; 95% CI: 2.11, 15.86) [124]. In contrast, recent data from a retrospective 
12-year cohort study of 75,432 women in Australia identified obesity as an independent risk factor for 
SGA compared to normal weight (adjusted OR 1.22; 95% CI: 1.14, 1.31) [130], similar to the 24% 
increased risk for SGA with maternal obesity in a multi-ethnic New Zealand population (adjusted OR 
1.24; CI: 1.11, 1.39) [131]. 
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Table 2. Odds ratios for adverse perinatal outcomes according to different pre-pregnancy/maternal body mass index. 
Study Population n BMI (kg/m2) 
Perinatal Outcome OR (95% CI) 
LGA SGA 
Retrospective case-control study (n = 100), UK a [132] Not reported ≥40.0 3.11 (1.25, 7.79) *  
Retrospective population-based cohort study of 5047 singleton nulliparous pregnancies, China b [133] 
579 <18.5  1.67 (1.07, 2.61) † 
926 24.0–27.9 1.46 (1.02, 2.08) †  
342 ≥28 1.91 (1.17, 3.10) †  
South Australian Pregnancy Outcome Unit, with singleton pregnancies (n = 19, 672) c [12] 
364 <18.5 0.38 (0.22, 0.67) 2.12 (1.58, 2.85) 
2943 25.0–29.9 1.59 (1.41, 1.81) 0.75 (0.61, 0.92) 
1528 30.0–34.9 1.60 (1.37, 1.85) 0.77 (0.59, 0.99) 
684 35.0–39.9 1.91 (1.58, 2.30) 1.12 (0.82, 1.52) 
453 ≥40.0 2.17 (1.76, 2.68) 0.56 (0.34, 0.94) 
Birth cohort study. Queensland, Australia d [126] 211 ≥30.0 2.73 (1.49, 5.01) - 
Singleton fetuses at the University of California (1981 through 2001). Weight measured on first  
pre-natal visit e [128] 
Not reported >29.0 
3.04 (1.86, 4.98) White - 
0.33 (0.04, 2.85) African American - 
2.93 (1.00, 8.58) Latina - 
3.55 (1.39, 9.07) Asian - 
Retrospective cohort study of women who had received prenatal care in the whole urban prenatal care 
centers of Kazerun, Iran f [129] 
816 <19.8 0.48 (0.30, 0.77) - 
682 26.0–29.9 1.27 (0.87, 1.86) - 
186 ≥29.0 1.21 (0.61, 2.41) - 
Prospective study in Thai women, at <28 weeks’ gestation g [125] 200 ≥27.5 1.4 (0.5, 4.3) - 
Danish cohort of women carrying singleton births h [127] 
116 <18.5 0.32 (0.27, 0.38) - 
3160 25.0–29.9 1.70 (1.60, 1.78) - 
1898 30.0–34.9 2.20 (2.08, 2.33) - 
1363 ≥35.0 2.73 (2.55, 2.94) - 
Retrospective cohort study among women and infants from the Better Outcomes Registry and Network 
dataset, Canada i [124] 
249 ≥40.0 3.70 (2.22, 6.16) 0.75 (0.38, 1.45) 
* Fetal macrosomia (≥4000 g) † Relative Risk; a Reference BMI category: 20.0–25.0 kg/m2. b Analysis adjusted for maternal age, maternal education, and gestational weight gain. Reference BMI category: 18.5–24.9 
kg/m2 (n = 3200). c Analysis adjusted for maternal age, parity, smoking status, and hospital status. Reference BMI category: 18.5–24.9 kg/m2 (n = 5,261). d Analysis adjusted for pre-pregnancy obesity, previous pregnancy, 
marital status, education level, and maternal smoking. Reference BMI category: <30 kg/m2. e Analysis adjusted for maternal age, parity, educational level, insurance status, gestational diabetes, gestational age, 
birthweight, induction of labor, use of epidural anesthesia, length of labor, and weight gain. Reference BMI category: 19.8–26.0 kg/m2. f Analysis adjusted for pre-pregnancy BMI and gestational weight gain, and 
additionally adjusted for maternal age, education level, occupation, family history of hypertension, family history of diabetes, and parity. Reference BMI category: 19.8–26.0 kg/m2. g Relative risk. Reference BMI 
category: 18.5–23.0 kg/m2. h Analysis adjusted for maternal age, parity, smoking during pregnancy, gestational age, birthweight, GDM, sex, and calendar year. BMI reference category: 18.5–24.0 kg/m2. i Analysis 
adjusted for maternal smoking, education quartile, and family income quartile. Reference BMI category: 18.5–24.9 kg/m2. 
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Several obesogenic models in animals have identified short-term consequences of maternal high fat 
feeding. In rats, exposure to maternal overnutrition or obesity during pregnancy was associated with 
obese offspring [134–138], with additive effects occurring when pups consumed a high fat diet  
post-weaning [139]. Overfeeding sheep from conception to mid-gestation to induce overweight and 
obesity also led to fetal overgrowth [140]. Other animal studies have investigated the long-term effects 
of excess maternal nutrition. One of the earliest was in the baboon, where overfeeding in the  
pre-weaning period permanently increased adiposity through larger fat cells; this was particularly 
evident in females [141]. Rats who were overfed to become obese prior to conception, were fed normally 
during pregnancy, and whose offspring were fed a normal diet, were more frequently obese as adults 
compared to controls [138]. Longer term high-fat feeding in rats also has been associated with 
insufficient placental function, reduced pup survival, and fetal death [142], suggesting that uterine stress 
as a result of maternal obesity alters proper development of the placental vasculature, leading to poor 
fetal development. 
Obesity and pregnancy also individually contribute to a state of chronic inflammation. Maternal high 
fat consumption programs the appetite-regulating system of offspring towards orexigenic pathways, 
leptin resistance, and adiposity [33]. Mechanisms underpinning the relationship between maternal 
obesity and adverse perinatal outcomes have been reported; however, a biologic pathway has not been 
established. Pro-inflammatory cytokines are elevated in obese compared to normal pregnancies [143], 
which can ultimately impact the maternal–fetal interface, leading to a higher risk of fetal infection and 
fetal complications [144]. Maternal obesity also can result in placental oxidative stress [145]. The 
increase in oxidative stress may impair placentation and establishment of sufficient blood supply, 
potentially impacting fetal metabolism [146]. The placenta is involved with the delivery of nutrients, 
oxygen, and hormones to the fetus, thus is ultimately responsible for the growth trajectory of the  
fetus [147]. 
Increasing pre-pregnancy BMI has been associated with increased placental weight and placental size, 
which were associated with adverse perinatal outcomes [148]; and maternal obesity was also associated 
with placenta insufficiency and increased placental lesions [149]. Moreover, IUGR is associated with 
placental insufficiency [150]. As maternal obesity can also be associated with undernutrition in the 
mother as well as the fetus (reviewed in [151]), neonatal consequences include IUGR but also altered 
epigenetic programming, which has been linked to later life disease in the offspring (reviewed in [152]). 
It is difficult to identify whether fetal programming with maternal overweight/obesity shares the same 
mechanisms of maternal undernutrition; the mechanisms underlying the way in which fetal systems cope 
with excess fuels during intrauterine development remain relatively unexplored. These findings provide 
evidence that excess BMI plays a significant role in altered in utero environment, which can have 
significant adverse effects on the fetus both in the short and longer term. 
Gestational Weight Gain 
The effects of maternal obesity on maternal and infant outcomes are further confounded by  
pre-pregnancy BMI [153,154] as well as excess gestational weight gain [155–158]. In two recent 
systematic reviews and meta-analyses, high gestational weight gain was associated with lower risk of 
LBW (RR 0.64; 95% CI: 0.53, 0.78) [159], whereas low total gestational weight gain (<12.5 kg to <7 kg 
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depending on pre-pregnancy BMI category) was associated with increased risk of LBW (RR 1.85; 95% 
CI: 1.72, 2.00) [160]. However, in a population-based cohort study of 3536 women with class 3 obesity, 
those who lost weight during pregnancy had increased risk for SGA babies (aOR 2.34; 95% CI: 1.15, 
4.76) [161]. Subsequent meta-analysis on interventions aimed at reducing gestational weight gain 
revealed there were no significant differences in birthweight between the dietary/physical activity 
intervention and control groups [162,163]. The IOM has recently revised gestational weight gain 
recommendations according to different BMI categories which attempt to improve the short- and  
long-term health of the mother and the child [164]. 
3.6. Summary 
The effects of maternal BMI on infant birthweight are important given the increasing prevalence of 
overweight and obesity in women of childbearing age. The strong evidence of association between 
childhood obesity and other metabolic abnormalities such as hypertension, diabetes, and cardiovascular 
disease signifies the importance of modifying body weight to an appropriate level prior to conception, 
to improve infant and adult outcomes. Although this is ideal, it is far from practical and is unlikely in a 
real-world situation. Dietary modification should be at the forefront of efforts to improve maternal health, 
regardless of BMI, in an effort to positively impact perinatal health. Further larger and more robust 
studies are required to identify the importance of limiting weight gain during pregnancy, and to follow up 
on longer term health outcomes in the mother, infant, and child. 
4. Conclusions 
This review summarizes comprehensive data from epidemiological studies and the latest evidence 
from RCTs on maternal dietary intakes and infant birthweight. Research to date has not identified  
an effective supplementation strategy to combat the adverse perinatal effects associated with suboptimal 
maternal diet; indeed, supplementation strategies may only be beneficial when a deficiency is observed. 
Thus, a complete understanding of the underlying dietary profile is warranted to avoid needless 
supplementation where no deficiency exists. In many cases, the mean birthweight of the study population 
was >3000 g, suggesting that any increases in birthweight that were identified may not be of clinical 
benefit. Suboptimal dietary intakes (intakes below recommended levels) occur not only in developing 
countries, but also in developed countries, irrespective of BMI. The global obesity epidemic brings new 
challenges in understanding, managing, and treating obesity in pregnancy, to improve both short- and 
long-term child health outcomes. Successful weight gain modifications show promise in reducing the 
risk of LGA babies but do not appear to modify rates of SGA. To date, the most promising results come 
from dietary pattern analyses, in which consumption of whole foods including fruit, vegetables,  
whole grains, low-fat dairy, and lean meats might be beneficial toward producing an infant of  
appropriate birthweight. 
This review has highlighted the inconsistencies between studies and the limited success of dietary 
interventions studies to improve infant outcomes. We have identified the need for further RCTs that are 
carefully implemented and targeted to women with clear dietary deficiencies, as well as the need to 
reduce the increasing prevalence of women entering pregnancy with an overweight BMI through dietary 
interventions. Understanding pre-conception diet also deserves attention as dietary intakes appear to 
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change minimally prior to and during pregnancy [165,166]. Up to 50% of pregnancies are unplanned [167]; 
therefore, informing women prior to pregnancy on the importance of healthy eating should be 
encouraged so as to maintain a healthy diet during pregnancy. 
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